Medicare Enrolled
Dr. Stuart Silverman, MD
Optician · Beverly Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Silverman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silverman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Silverman
Dr. Stuart Silverman is an optician specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Silverman performed 40,688 Medicare services across 1,949 unique beneficiaries.
Between the years covered by Open Payments, Dr. Silverman received a total of $375,546 from 59 pharmaceutical and/or device companies across 1318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Silverman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$375,546 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,688
Medicare services
Top 3% in CA for optician
1,949
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 19,500 | $18 | $29 |
| Romosozumab injection (Evenity) for osteoporosis | 18,480 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,056 | $97 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
470 | $11 | $45 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
228 | $34 | $100 |
| Bone density scan (DEXA) of forearm, finger, hand, or foot A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture. |
196 | $36 | $75 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
189 | $44 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
162 | $134 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $70 | $130 |
| New patient office visit, complex (60-74 min) | 64 | $180 | $345 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
52 | $59 | $154 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
47 | $37 | $100 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
43 | $81 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $45 | $65 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
19 | $11 | $80 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
12 | $53 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$375,546
Total received (2018-2024)
Avg $53,649/year across 7 years
Top 2% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,318
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$261,863 (69.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,140 (26.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,543 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,705
2023
$29,556
2022
$4,870
2021
$48,753
2020
$80,823
2019
$106,599
2018
$94,239
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sandoz Inc.
$7,700
Amgen Inc.
$668
ABBVIE INC.
$504
Radius Health, Inc.
$416
Novartis Pharmaceuticals Corporation
$327
Alvogen Inc
$222
PFIZER INC.
$143
UCB, Inc.
$120
Janssen Biotech, Inc.
$105
Mallinckrodt Hospital Products Inc.
$89
AstraZeneca Pharmaceuticals LP
$81
GlaxoSmithKline, LLC.
$74
Aurinia Pharma U.S., Inc.
$42
Dompe US, Inc.
$37
Lilly USA, LLC
$32
SHIELD THERAPEUTICS INC
$30
Phathom Pharmaceuticals, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$26
Octapharma USA, Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 82.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$114,920
Radius Health, Inc.
$90,751
Eli Lilly and Company
$84,041
Lilly USA, LLC
$45,388
GlaxoSmithKline, LLC.
$9,720
PFIZER INC.
$8,652
Sandoz Inc.
$7,700
Celltrion, Inc.
$2,737
Janssen Biotech, Inc.
$1,816
Novartis Pharmaceuticals Corporation
$1,242
Alexion Pharmaceuticals, Inc.
$928
ABBVIE INC.
$918
UCB, Inc.
$828
Celgene Corporation
$632
AbbVie Inc.
$531
Ultragenyx Pharmaceutical Inc.
$468
AstraZeneca Pharmaceuticals LP
$450
GENZYME CORPORATION
$418
Mallinckrodt Hospital Products Inc.
$357
AbbVie, Inc.
$337
Alvogen Inc
$319
NOVARTIS PHARMACEUTICALS CORPORATION
$297
Aurinia Pharma U.S., Inc.
$246
Gilead Sciences, Inc.
$193
Nestle HealthCare Nutrition Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
Janssen Scientific Affairs, LLC
$103
Biohaven Pharmaceuticals, Inc.
$91
Horizon Therapeutics plc
$87
Fresenius Kabi USA, LLC
$80
Dompe US, Inc.
$65
SANOFI PASTEUR INC.
$61
Biohaven Pharmaceutical Holding Company Ltd.
$61
IDORSIA PHARMACEUTICALS US INC
$55
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$47
Octapharma USA, Inc.
$46
Collegium Pharmaceutical, Inc.
$44
SOBI, INC
$39
DePuy Synthes Sales Inc.
$37
Regeneron Healthcare Solutions, Inc.
$37
Allergan Inc.
$36
Allergan, Inc.
$36
NESTLE HEALTHCARE NUTRITION INC.
$33
Sobi, Inc
$33
Eisai Inc.
$31
SHIELD THERAPEUTICS INC
$30
Phathom Pharmaceuticals, Inc.
$29
Mallinckrodt Enterprises LLC
$28
Kyowa Kirin, Inc.
$26
Kiniksa Pharmaceuticals International, plc
$26
Exact Sciences Corporation
$20
Arbor Pharmaceuticals, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
IBSA Pharma Inc.
$18
Azurity Pharmaceuticals, Inc.
$16
Zimmer Biomet Holdings, Inc.
$14
Purdue Pharma L.P.
$12
Romark Laboratories, LC
$11
Top 3 companies account for 77.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AJOVY · AMJEVITA · AVSOLA · Aimovig · Alinia Tablets 500mg 30 count bottle · Arcalyst · BENLYSTA · CERDELGA · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COSENTYX · CYLTEZO · Cologuard Collection Kit · Crysvita · Cryvista · DISEASE STATE · DUPIXENT · Dayvigo · EUCRISA · EVENITY · Edarbi · Enbrel · FORTEO · GILENYA · HORIZANT · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LINZESS · LUCEMYRA · LUPKYNIS · LYRICA · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORTHOVISC · OXERVATE · Otezla · Prolia · QUVIVIQ · RELISTOR · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYMPROIC · Sports Medicine Product Portfolio · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tirosint · Trintellix · Truvada · Tymlos · UBRELVY · VOQUEZNA · XELJANZ · XENPOZYME · XTAMPZA · Xtampza ER · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for optician in CA.
Geographic Context
Opticians within 10 mi
1,542
Per 100K population
15.7
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Silverman is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with consulting-driven industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Silverman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Silverman performed 19,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Silverman receive payments from pharmaceutical companies?
Yes. Dr. Silverman received a total of $375,546 from 59 companies across 1,318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silverman's costs compare to other opticians in Beverly Hills?
Dr. Silverman's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silverman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Beverly Hills
Browse opticians in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Radius Health, Inc. Payments to Doctors
See all physicians who received payments from Radius Health, Inc.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology